Immutep (ASX:IMM) has announced promising new data from its Phase IIb TACTI-003 trial, presented at the ESMO Immuno-Oncology Congress 2024.

US stocks surged overnight, with the Nasdaq Composite closing above 20,000 for the first time. Latest US CPI data boosts rate cut expectations.

US inflation rose to an annual rate of 2.7% in November, up from 2.6% in October, according to Consumer Price Index (CPI) data released on Wednesday by the Bureau of Labor Statistics. The monthly ...

INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and ...

Shares in Alphabet (NASDAQ: GOOGL) rose more than 5% on Tuesday after the company announced the development of its new ...

Perpetual (ASX:PPT) has provided an update on its proposed scheme of arrangement with KKR, revealing that tax complications ...

Integral Diagnostics (ASX:IDX) has secured clearance from the ACCC for its proposed acquisition of Capitol Health (ASX:CAJ).

BrainChip (ASX:BRN) has been awarded a US$1.8m contract with the US Air Force Research Laboratory (AFRL) to develop ...

China's Communist Party has shifted its monetary policy stance to 'moderately loose' from 'prudent' for the first time since ...

Immutep (ASX:IMM) has announced the initiation of its TACTI-004 Phase III clinical trial, which aims to evaluate the efficacy ...

Visioneering Technologies (ASX:VTI) has announced plans to delist from the ASX, with a vote scheduled for 10 January 2025.

US stocks have closed lower, with the Dow Jones Industrial Average down for the fourth consecutive session. The Dow shed 154.10 points, or 0.35%, to close at 44,247.83. The S&P 500 dropped 0.3% to ...